Document Detail


Very high users of platelet transfusions in the neonatal intensive care unit.
MedLine Citation:
PMID:  19175546     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: In neonatal intensive care unit (NICU) practice, a small percentage of the patients receive a large proportion of the platelet (PLT) transfusions administered. This study sought to better define this very-high-user group. To accomplish this, records of all NICU patients in a multihospital health care system who, during a recent 5(1/2)-year period, received 20 or more PLT transfusions were examined. STUDY DESIGN AND METHODS: Electronic medical record repositories of Intermountain Healthcare neonates with dates of birth from January 1, 2002, through June 30, 2007, who received 20 or more PLT transfusions were identified. The causes of the thrombocytopenia were sought, whether each transfusion given was a treatment for bleeding versus prophylaxis was determined, whether each transfusion was compliant with our transfusion guidelines was judged, and the outcomes were tabulated. RESULTS: During this period, 45 patients received 20 or more PLT transfusions (median, 29; range, 20-79). Medical conditions could be categorized into six diagnoses: 1) extracorporeal membrane oxygenation (ECMO) for congenital diaphragmatic hernia (CDH; n = 13), 2) fungal sepsis (n = 8), 3) ECMO for reasons other than CDH (n = 8), 4) necrotizing enterocolitis (n = 7), 5) bacterial sepsis (n = 7), and 6) congenital hyporegenerative thrombocytopenia (n = 2). Nineteen percent of the transfusions were ordered for oozing, bruising, or bleeding and 81 percent for prophylaxis. Thirty-six percent of transfusions were given in violation of our transfusion guidelines. Forty-nine percent of the high users died, but no deaths were due to hemorrhage. All survivors developed chronic lung disease, and all survivors weighing less than 1250 g at birth developed retinopathy of prematurity. CONCLUSIONS: Almost all patients that received 20 or more PLT transfusions had an acquired, consumptive thrombocytopenia. All could have received fewer transfusions had the guidelines already in place been observed. Eighty-one percent fewer PLT transfusions would have been administered had the paradigm been transfusing only if oozing, bruising, or bleeding was present.
Authors:
M Lynn Dohner; Susan E Wiedmeier; Ronald A Stoddard; Donald Null; Diane K Lambert; Jill Burnett; Vickie L Baer; Joshua C Hunt; Erick Henry; Robert D Christensen
Related Documents :
18291186 - Comparison of mini-cardiopulmonary bypass system with air-purge device to conventional ...
19924436 - An evaluation of the utility of additional tests in the preoperative diagnostics of acu...
22519366 - Transfusion-related mortality after primary hip arthroplasty - an analysis of mechanism...
15952316 - Cognitive dysfunction following cardiovascular surgery.
20027086 - An "all 5-mm ports" versus conventional ports approach to laparoscopic cholecystectomy ...
23125086 - Propolis modulates vitronectin, laminin, and heparan sulfate/heparin expression during ...
Publication Detail:
Type:  Journal Article     Date:  2009-01-21
Journal Detail:
Title:  Transfusion     Volume:  49     ISSN:  1537-2995     ISO Abbreviation:  Transfusion     Publication Date:  2009 May 
Date Detail:
Created Date:  2009-05-11     Completed Date:  2009-06-02     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0417360     Medline TA:  Transfusion     Country:  United States    
Other Details:
Languages:  eng     Pagination:  869-72     Citation Subset:  IM    
Affiliation:
Department of Women and Newborns, Intermountain Healthcare, Ogden, Utah 84403, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Guideline Adherence*
Hemorrhage / prevention & control,  therapy
Humans
Infant, Newborn
Intensive Care Units, Neonatal*
Lung Diseases / etiology
Outcome Assessment (Health Care)
Platelet Transfusion / utilization*
Survival Rate
Thrombocytopenia / complications,  etiology,  mortality,  therapy*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Assessment of safety in neonates for transfusion of platelets and plasma prepared with amotosalen ph...
Next Document:  P-selectin mRNA is maintained in platelet concentrates stored at 4 degrees C.